Brain MRI results of DECIDE: a randomized, double-blind trial of DAC HYP vs. IFNβ-1a in RRMS patients

被引：0

作者：

Arnold, D. L. ^{[1
,2
]}

Kappos, L. ^{[3
]}

Havrdova, E. ^{[4
]}

Selmaj, K. ^{[5
]}

Boyko, A. ^{[6
]}

Kaufman, M. ^{[7
]}

Wiendl, H. ^{[8
]}

Rose, J. ^{[9
]}

Greenberg, S. ^{[10
]}

Demirhan, E. ^{[11
]}

Sweetser, M. ^{[11
]}

Riester, K. ^{[11
]}

Elkins, J. ^{[11
]}

机构：

[1] NeuroRx Res, Montreal, PQ, Canada

[2] McGill Univ, Montreal, PQ, Canada

[3] Univ Basel Hosp, CH-4031 Basel, Switzerland

[4] Charles Univ Prague, Sch Med 1, Prague, Czech Republic

[5] Med Univ Lodz, Lodz, Poland

[6] Moscow Multiple Sclerosis Ctr, Moscow, Russia

[7] Carolinas Med Ctr, Charlotte, NC 28203 USA

[8] Univ Munster, D-48149 Munster, Germany

[9] Univ Utah, Sch Med, Salt Lake City, UT USA

[10] Abbvie Biotherapeut Inc, Redwood City, CA USA

[11] Biogen Idec Inc, Cambridge, MA USA

来源：

MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P051

引用

页码：89 / 90

页数：2

共 50 条

[21] A double-blind randomized trial of 0.1% tacrolimus vs. 0.05% cloβsol for the treatment of childhood vitiligo
Lepe, V
Moncada, B
Castanedo, JP
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 342 - 342
[22] Dual vs. triple therapy for childhood Helicobacter pylori gastritis:: a double-blind randomized multicentre trial
Oderda, G
Marinello, D
Lerro, P
Kuvidi, M
de'Angelis, GL
Ferzetti, A
Cucchiara, S
Franco, MT
Romano, C
Strisciuglio, P
Pensabene, L
HELICOBACTER, 2004, 9 (04) : 293 - 301
[23] CRANBERRY SYRUP VS. TRIMETHOPRIM IN THE PROPHYLAXIS OF RECURRENT URINARY INFECTION: A DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL
Uberos, J.
Rodriguez-Belmonte, R.
Fernandez-Puentes, V.
Narbona-Lopez, E.
Molina-Carballo, A.
Munoz-Hoyos, A.
ACTA PAEDIATRICA, 2010, 99 : 48 - 48
[24] Remifentanil vs. alfentanil infusion in non-paralysed patients:: a randomized, double-blind study
Mortensen, CR
Larsen, B
Petersen, JÅK
Rotboll, P
Riis, J
Thorshauge, H
Engbæk, J
Troelsen, S
Viby-Mogensen, J
EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2004, 21 (10) : 787 - 792
[25] OXPRENOLOL VS PROPRANOLOL - A RANDOMIZED, DOUBLE-BLIND, MULTICLINIC TRIAL IN HYPERTENSIVE PATIENTS TAKING HYDROCHLOROTHIAZIDE
THOMAS, JR
HYPERTENSION, 1981, 3 (02) : 250 - 256
[26] A double-blind, randomized controlled trial of gabapentin vs. placebo for acute pain management in critically ill patients with rib fractures
Moskowitz, Eliza E.
Garabedian, Lucin
Harden, Kimberly
Perkins-Pride, Emily
Asfaw, Menilik
Preslaski, Candice
Liasia, Kiara N.
Lawless, Ryan
Burlew, Clay Cothren
Pieracci, Fredric
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2018, 49 (09): : 1693 - 1698
[27] Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial
Oldgren, Jonas
Budaj, Andrzej
Granger, Christopher B.
Khder, Yasser
Roberts, Juliet
Siegbahn, Agneta
Tijssen, Jan G. P.
Van de Werf, Frans
Wallentin, Lars
EUROPEAN HEART JOURNAL, 2011, 32 (22) : 2781 - 2789
[28] Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in Photosensitive Epilepsy Patients
Ronald C. Reed
William E. Rosenfeld
Susan M. Lippmann
Rene M. J. C. Eijkemans
Dorothee G. A. Kasteleijn-Nolst Trenité
CNS Drugs, 2020, 34 : 1075 - 1086
[29] Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in Photosensitive Epilepsy Patients
Reed, Ronald C.
Rosenfeld, William E.
Lippmann, Susan M.
Eijkemans, Rene M. J. C.
Kasteleijn-Nolst Trenite, Dorothee G. A.
CNS DRUGS, 2020, 34 (10) : 1075 - 1086
[30] Daclizumab high-yield process (DAC HYP) vs. intramuscular interferon beta-1a in subgroups predictive of active disease: results from the DECIDE study
Wiendl, H.
Havrdova, E.
Rose, J.
Giovannoni, G.
Tsao, L. C.
Zhao, J.
Pan, Q.
Elkins, J.
Greenberg, S. J.
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 232 - 233

← 1 2 3 4 5 →